Form 4: Avanos Medical Director Patrick J. O'Leary Acquires 12,003 Shares Through Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Patrick J. O'Leary acquired 12,003 shares of Avanos Medical, Inc. through restricted stock units on January 2, 2025.

Summary

  • Patrick J. O'Leary, a director at Avanos Medical, Inc., acquired 12,003 shares of common stock on January 2, 2025.
  • The acquisition was through the issuance of restricted stock units (RSUs) as part of the company's Outside Directors' Compensation Plan.
  • The price per share for the RSU grant was $0.
  • Following the transaction, O'Leary's total direct holdings in Avanos Medical, Inc. increased to 66,643 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

  • The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
  • The use of restricted stock units aligns the director's interests with those of the shareholders.

Industry Context

This is a standard transaction for a director receiving compensation in the form of equity. It is common practice for companies to use RSUs as part of their compensation plans for directors and executives.

Comparison to Industry Standards

  • The use of restricted stock units (RSUs) for director compensation is a common practice across many publicly traded companies, including those in the medical device industry.
  • Companies like Medtronic and Stryker also use equity-based compensation to align the interests of their directors with those of shareholders.
  • The specific number of shares and vesting schedules can vary based on company size, performance, and individual director agreements.

Stakeholder Impact

  • The acquisition of shares by a director can be viewed positively by shareholders as it indicates confidence in the company's future performance.

Key Dates

DateDescription
01/02/2025Date of the transaction where Patrick J. O'Leary acquired 12,003 shares through restricted stock units.
01/06/2025Date the form was signed by Mojirade James, as attorney-in-fact for Patrick J. O'Leary.

Keywords

Avanos Medical, Director, Patrick J. O'Leary, Restricted Stock Units, RSU, Share Acquisition, Insider Trading, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.